Editorial comment from Dr Shiota to Prognostic impact of young age on stage IV prostate cancer treated with primary androgen deprivation therapy

Int J Urol. 2014 Jun;21(6):583-4. doi: 10.1111/iju.12397. Epub 2014 Jan 9.

Author

Masaki Shiota¹

Affiliation

¹ Department of Urology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan. shiota@uro.med.kyushu-u.ac.jp.

PMID: 24404863
DOI: 10.1111/iju.12397

No abstract available

Publication types

Editorial
Comment

MeSH terms

Androgen Antagonists / therapeutic use*
Humans
Male
Prostatic Neoplasms / drug therapy*
Prostatic Neoplasms / pathology*

Substances

Androgen Antagonists